Effect of placenta growth factor-1 on proliferation and release of nitric oxide, cyclic AMP and cyclic GMP in human epithelial cells expressing the FLT-1 receptor

Growth Factors. 2001;19(3):193-206. doi: 10.3109/08977190109001086.

Abstract

We investigated the effect of placenta growth factor-1 (P1GF-1) on cell growth and on the release of nitric oxide (NO), cyclic AMP (cAMP) and cyclic GMP (cGMP) in human malignant epithelial cells. A noteworthy increase in proliferation was induced in choriocarcinoma cells (BeWo) by P1GF-1 treatment, while breast cancer cells (CG-5) were minimally affected. Western blotting and immunocytochemistry demonstrated the expression of the P1GF-1 receptor fms-like tyrosine kinase-1 (Flt-1) in these models. NO was released in the BeWo culture medium as a result of P1GF-1 treatment, with maximal induction occurring after 6 h. Enhanced cAMP levels were observed after 80 min-6 h, while the amounts of cGMP produced were undetectable. In summary, PIGF-1 stimulates the proliferation of cell types that express Flt-1, other than endothelial cells. In BeWo cells, this effect is preceded by the induction of NO and cAMP as probable downstream effectors of Flt-1 activation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blotting, Western
  • Cell Division
  • Cell Line
  • Cyclic AMP / metabolism
  • Cyclic GMP / metabolism*
  • Dose-Response Relationship, Drug
  • Epithelial Cells
  • Extracellular Matrix Proteins / metabolism*
  • Humans
  • Immunohistochemistry
  • Nitric Oxide / metabolism*
  • Placenta / metabolism
  • Placenta Growth Factor
  • Pregnancy Proteins / metabolism*
  • Protein Binding
  • Time Factors
  • Tumor Cells, Cultured
  • Umbilical Veins / cytology
  • Vascular Endothelial Growth Factor Receptor-1

Substances

  • Extracellular Matrix Proteins
  • PGF protein, human
  • Pregnancy Proteins
  • Placenta Growth Factor
  • Nitric Oxide
  • Cyclic AMP
  • FLT1 protein, human
  • Vascular Endothelial Growth Factor Receptor-1
  • Cyclic GMP